Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia
Xueliang Gao, … , Xue-Zhong Yu, Haizhen Wang
Xueliang Gao, … , Xue-Zhong Yu, Haizhen Wang
Published July 13, 2021
Citation Information: J Clin Invest. 2021;131(16):e143119. https://doi.org/10.1172/JCI143119.
View: Text | PDF
Research Article Cell biology Oncology

Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia

  • Text
  • PDF
Abstract

PFKP (phosphofructokinase, platelet), the major isoform of PFK1 expressed in T cell acute lymphoblastic leukemia (T-ALL), is predominantly expressed in the cytoplasm to carry out its glycolytic function. Our study showed that PFKP is a nucleocytoplasmic shuttling protein with functional nuclear export and nuclear localization sequences (NLSs). Cyclin D3/CDK6 facilitated PFKP nuclear translocation by dimerization and by exposing the NLS of PFKP to induce the interaction between PFKP and importin 9. Nuclear PFKP stimulated the expression of C-X-C chemokine receptor type 4 (CXCR4), a chemokine receptor regulating leukemia homing/infiltration, to promote T-ALL cell invasion, which depended on the activity of c-Myc. In vivo experiments showed that nuclear PFKP promoted leukemia homing/infiltration into the bone marrow, spleen, and liver, which could be blocked with CXCR4 antagonists. Immunohistochemical staining of tissues from a clinically well-annotated cohort of T cell lymphoma/leukemia patients showed nuclear PFKP localization in invasive cancers, but not in nonmalignant T lymph node or reactive hyperplasia. The presence of nuclear PFKP in these specimens correlated with poor survival in patients with T cell malignancy, suggesting the potential utility of nuclear PFKP as a diagnostic marker.

Authors

Xueliang Gao, Shenghui Qin, Yongxia Wu, Chen Chu, Baishan Jiang, Roger H. Johnson, Dong Kuang, Jie Zhang, Xi Wang, Anand Mehta, Kenneth D. Tew, Gustavo W. Leone, Xue-Zhong Yu, Haizhen Wang

×

Figure 1

PFKP is a nucleocytoplasmic shuttling protein.

Options: View larger image (or click on image) Download as PowerPoint
PFKP is a nucleocytoplasmic shuttling protein.
(A) GO enrichment analysi...
(A) GO enrichment analysis showing that PFKP interacts with multiple proteins functioning in regulation of nuclear transcription (colored circles with highest protein counts). Source data from 123 literature-curated PFKP-interacting proteins were obtained from the BioGRID database. “Protein Counts” indicates the number of proteins interacting with PFKP in each functional annotation cluster. (B and C) PFKP nuclear localization relies on importins and exportins. (B) Immunoblotting (IB) shows decreased PFKP in nuclear extract (NE) of cells treated with the importin inhibitor, importazole (Impor) (40 μM, 24 hours). (C) Increased PFKP in the nuclei of cells treated with the exportin inhibitor, leptomycin B (LMB) (5 ng/mL, 24 hours). CE, cytoplasmic extract. (D and E) Nuclear-to-cytoplasmic ratios of GFP protein expression from DU145 cells expressing NES-GFP (D) or NLS-fused GFP (E). IB of GFP was quantified using ImageJ (NIH). GFP vector served as control. (F) Nuclear enrichment of PFKP NES mutant. (G) Reduced nuclear accumulation of PFKP NLS mutant. In F and G, IB was performed on the NEs and CEs of cells expressing FLAG-tagged PFKP (left) with an anti-FLAG antibody. The graph on the right shows the NE/CE ratios of FLAG-PFKP. Lamin A/C is a nuclear protein marker. Tubulin is a cytoplasmic protein marker. (H) Localization of functional NESs (NES1 in green, NES2 in blue, left) and NLS (in red, right) in the structure of the tetrameric PFKP protein. Functional NLS localizes at the interface in the dimeric form of PFKP. Pymol software was applied for protein structure analysis, and the structure of human PFKP (DOI: 10.2210/pdb4U1R/pdb) was downloaded from the Protein Data Bank (37). n = 3 (B–G). Data represent mean ± SEM. *P < 0.05; **P < 0.01; ****P < 0.0001 by 2-tailed Student’s t test (F and G) or 1-way ANOVA (D and E).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts